Conversations in Oncology: Updates in the Treatment of Early Non-Small Cell Lung Cancer скачать в хорошем качестве

Conversations in Oncology: Updates in the Treatment of Early Non-Small Cell Lung Cancer

Adjuvant therapy in Early-Stage NSCLC Certified AMA/ANCC Activity With the recent approval of atezolizumab and osimertinib, and several ongoing trials, it has become clear that immunotherapy and targeted approaches are gaining ground in the adjuvant and neoadjuvant setting of early-stage non-small cell lung cancer (NSCLC). Considering the continual updates from clinical trials in this space, it is pivotal that healthcare professionals are familiar with the practical considerations to safely integrate this recent progress. This activity will highlight the practice-changing updates in adjuvant and neoadjuvant approaches in early-stage NSCLC, to enable safe and effective implementation into clinical practice through expert-guided discussions with Drs. Julie Brahmer, Jamie Chaft and Stephen Liu. FACULTY Julie R. Brahmer, MD, MSc Co-Director, Division of Upper Aerodigestive Cancer Program Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Jamie Chaft, MD Associate Attending Physician Memorial Sloan Kettering Cancer Center Associate Professor Weill Cornell Medical College Stephen Liu, MD Associate Professor of Medicine Director of Thoracic Oncology Director of Developmental Therapeutics Lombardi Comprehensive Cancer Center Georgetown University Review the video(s) at https://bit.ly/3dc0eUw to claim AMA/ANCC credit after completion of the brief Post-Test/Evaluation(s). This activity is jointly provided by the University of Nebraska Medical Center and Practice Point Communications Supported by an independent educational grant from Merck Sharp & Dohme, LLC.